FOXD1-dependent RalA-ANXA2-Src complex promotes CTC formation in breast cancer
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
FOXD1-dependent RalA-ANXA2-Src complex promotes CTC formation in breast cancer
Authors
Keywords
-
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 41, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-10-13
DOI
10.1186/s13046-022-02504-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Development of 2'-aminospiro [pyrano[3,2–c]quinoline]-3'-carbonitrile derivatives as non-ATP competitive Src kinase inhibitors that suppress breast cancer cell migration and proliferation
- (2021) Mohamed Ramadan et al. BIOORGANIC CHEMISTRY
- RASSF1C oncogene elicits amoeboid invasion, cancer stemness, and extracellular vesicle release via a SRC/Rho axis
- (2021) Maria Laura Tognoli et al. EMBO JOURNAL
- A risk prediction model of DNA methylation improves prognosis evaluation and indicates gene targets in prostate cancer
- (2020) Enchong Zhang et al. Epigenomics
- A novel protein encoded by circFNDC3B inhibits tumor progression and EMT through regulating Snail in colon cancer
- (2020) Zihao Pan et al. Molecular Cancer
- FOXD1‐AS1 regulates FOXD1 translation and promotes gastric cancer progression and chemoresistance by activating the PI3K/AKT/mTOR pathway
- (2020) Qiong Wu et al. Molecular Oncology
- miR‐30a inhibits androgen‐independent growth of prostate cancer via targeting MYBL2, FOXD1, and SOX4
- (2020) Xinjun Li et al. PROSTATE
- LncRNA OIP5-AS1 promotes the malignancy of pancreatic ductal adenocarcinoma via regulating miR-429/FOXD1/ERK pathway
- (2020) Liping Wu et al. Cancer Cell International
- A novel regulatory loop miR-101/ANXA2/EGR1 mediates malignant characteristics of liver cancer stem cells
- (2020) Sai Ma et al. CARCINOGENESIS
- Clinical Significance of Annexin A2 Expression in Breast Cancer Patients
- (2020) Lee D. Gibbs et al. Cancers
- ERK2 regulates epithelial-to-mesenchymal plasticity through DOCK10-dependent Rac1/FoxO1 activation
- (2019) Sejeong Shin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting ERK1/2 protein-serine/threonine kinases in human cancers
- (2019) Robert Roskoski PHARMACOLOGICAL RESEARCH
- LKB1 deficiency renders non-small-cell lung cancer cells sensitive to ERK inhibitors.
- (2019) Elisa Caiola et al. Journal of Thoracic Oncology
- Plasma CCL5 promotes EMT-medicated epirubicin-resistance in locally advanced breast cancer
- (2018) Ge Ma et al. Cancer Biomarkers
- Circulating tumor cells undergoing EMT provide a metric for diagnosis and prognosis of patients with hepatocellular carcinoma
- (2018) Lu-Nan Qi et al. CANCER RESEARCH
- Is the incidence of advanced-stage breast cancer affected by whether women attend a steady-state screening program?
- (2018) Linda de Munck et al. INTERNATIONAL JOURNAL OF CANCER
- FGFR1-ERK1/2-SOX2 axis promotes cell proliferation, epithelial–mesenchymal transition, and metastasis in FGFR1-amplified lung cancer
- (2018) Kaixuan Wang et al. ONCOGENE
- Organ-specific metastasis of breast cancer: molecular and cellular mechanisms underlying lung metastasis
- (2018) Meysam Yousefi et al. CELLULAR ONCOLOGY
- LSD1 activation promotes inducible EMT programs and modulates the tumour microenvironment in breast cancer
- (2018) T. Boulding et al. Scientific Reports
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- TRIM65 supports bladder urothelial carcinoma cell aggressiveness by promoting ANXA2 ubiquitination and degradation
- (2018) Wen-Su Wei et al. CANCER LETTERS
- Loss of neural crest-associated gene FOXD1 impairs melanoma invasion and migration via RAC1B downregulation
- (2018) Huizi Wu et al. INTERNATIONAL JOURNAL OF CANCER
- Phosphorylation status at Smad3 linker region modulates TGF-β-induced EMT and cancer progression
- (2018) Akira Ooshima et al. CANCER SCIENCE
- Detection of HER2-positive Circulating Tumor Cells Using the LiquidBiopsy System in Breast Cancer
- (2018) Weirong Chen et al. Clinical Breast Cancer
- Signaling Pathways Induced by Leptin during Epithelial–Mesenchymal Transition in Breast Cancer
- (2018) Monserrat Olea-Flores et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Med19 is targeted by miR-101–3p/miR-422a and promotes breast cancer progression by regulating the EGFR/MEK/ERK signaling pathway
- (2018) Xiufen Zhang et al. CANCER LETTERS
- A conduit to metastasis: circulating tumor cell biology
- (2017) Douglas S. Micalizzi et al. GENES & DEVELOPMENT
- Cancer metastasis through the prism of epithelial-to-mesenchymal transition in circulating tumor cells
- (2017) Douglas S. Micalizzi et al. Molecular Oncology
- RAL GTPases: Biology and Potential as Therapeutic Targets in Cancer
- (2017) Chao Yan et al. PHARMACOLOGICAL REVIEWS
- Breast tumor cell-specific knockout ofTwist1inhibits cancer cell plasticity, dissemination, and lung metastasis in mice
- (2017) Yixiang Xu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Breast cancer metastasis: Putative therapeutic role of vascular cell adhesion molecule-1
- (2017) Rohit Sharma et al. CELLULAR ONCOLOGY
- A RasGAP, DAB2IP, regulates lipid droplet homeostasis by serving as GAP toward RAB40C
- (2017) Xiaomin Luo et al. Oncotarget
- Ral signaling pathway in health and cancer
- (2017) Adel Rezaei Moghadam et al. Cancer Medicine
- FOXD1–ALDH1A3 Signaling Is a Determinant for the Self-Renewal and Tumorigenicity of Mesenchymal Glioma Stem Cells
- (2016) Peng Cheng et al. CANCER RESEARCH
- Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline
- (2016) Lyndsay N. Harris et al. JOURNAL OF CLINICAL ONCOLOGY
- Circulating tumor cells in breast cancer
- (2016) Francois-Clement Bidard et al. Molecular Oncology
- FOXD1 promotes breast cancer proliferation and chemotherapeutic drug resistance by targeting p27
- (2015) Yi-Fan Zhao et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Annexin II-dependent actin remodelling evoked by hydrogen peroxide requires the metalloproteinase/sphingolipid pathway
- (2015) Christel Cinq-Frais et al. Redox Biology
- Classification of Circulating Tumor Cells by Epithelial-Mesenchymal Transition Markers
- (2015) Shiyang Wu et al. PLoS One
- Effect of Breast Conservation Therapy vs Mastectomy on Disease-Specific Survival for Early-Stage Breast Cancer
- (2014) Shailesh Agarwal et al. JAMA Surgery
- The EMT activator ZEB1 promotes tumor growth and determines differential response to chemotherapy in mantle cell lymphoma
- (2013) E Sánchez-Tilló et al. CELL DEATH AND DIFFERENTIATION
- Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
- (2013) M. Yu et al. SCIENCE
- Targeting the MAPK–RAS–RAF signaling pathway in cancer therapy
- (2012) Libero Santarpia et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Tumor Metastasis: Molecular Insights and Evolving Paradigms
- (2011) Scott Valastyan et al. CELL
- Tyrosine 23 Phosphorylation-Dependent Cell-Surface Localization of Annexin A2 Is Required for Invasion and Metastases of Pancreatic Cancer
- (2011) Lei Zheng et al. PLoS One
- Identification of Gliotropic Factors That Induce Human Stem Cell Migration to Malignant Tumor
- (2009) Jeung Hee An et al. JOURNAL OF PROTEOME RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search